Navigation Links
Nucletron Announces 2008 Results

VEENENDAAL, The Netherlands, April 24 /PRNewswire/ --

- Strong Product Offerings and Leadership in Brachytherapy Contribute to All-Time High

Nucletron, a global leader in radiation oncology, today announced strong financial results in 2008 with net sales of EUR112.4 million (US $165 million). EBITDA in 2008 ended at an all time high (in constant currencies) of EUR17 million with a strong fourth quarter contributing significantly to the year-end success. Despite challenging global economic conditions, Nucletron surpassed projections in 2008 due in large part to a renewed focus on brachytherapy treatment and an expanding product offering in external beam treatment planning software solutions.

Among the several advancements announced in 2008 was the introduction on Oncentra(R) Brachy, a new comprehensive volume-based treatment planning solution that optimizes cancer treatment planning with brachytherapy. Additionally, Oncentra(R) RT Viewer received clearance in 2008. Oncentra RT Viewer enables clinicians to review radiotherapy plans generated with a wide variety of DICOM-compliant treatment planning systems in a Windows (PC) environment.

"In the second half of 2008, we improved our focus on innovation and marketing efforts, while strengthening our management team. Given our many upcoming product releases in the months to come, we are on track to achieve our 2009 goals as planned," said Jos Lamers, chief executive officer of Nucletron.

About Nucletron

Nucletron is a global leader in Radiation Oncology, working with clinical teams to realize innovative solutions that improve patient care. Nucletron strives to offer the best possible choice of radiation modalities through integrated products, software and services. Critical to the Nucletron philosophy is the establishment of close working relationships with individual clinical teams - reconfiguring traditional boundaries between customer and solution provider. Many Nucletron employees have clinical experience delivering oncology care, providing an in-depth understanding of the complex needs of clinicians. For more information, visit

SOURCE Nucletron B V
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Nucletron Announces Market Release of First Commercially Available Software to Review and Share Dicom-Based Treatment Plans for Radiotherapy
2. Nucletron Announces Oncentra(R) Brachy* Treatment Planning Solution for Multimodality Environment
3. Keryx Biopharmaceuticals, Inc. Announces Michael P. Tarnok as Interim Chairman and Chief Executive Officer
4. Wyeth Announces Full Redemption of $2 Convertible Preferred Stock
5. OmniComm Systems Announces 1st Quarter Results of Operations
6. Medivation Announces Upcoming Scientific Presentations at Medical Conferences
7. China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results
8. Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast
9. Access Pharmaceuticals Announces the European Launch of MuGard(TM) by its European Partner, SpePharm
10. Metabolex Announces Election of Kurt von Emster to Board of Directors
11. Yongye Biotechnology Announces Preliminary Results for its Fiscal Quarter Ended March 31, 2009
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Houston Methodist ... the Cy-Fair Sports Association to serve as their ... agreement, Houston Methodist Willowbrook will provide sponsorship support, ... connectivity with association coaches, volunteers, athletes and families. ... the Cy-Fair Sports Association and to bring Houston ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... today announced the launch of the Supplyframe Design Lab . Located in ... to explore the future of how hardware projects are designed, built and brought ...
(Date:6/23/2016)... Andrew D Zelenetz ... Published recently in Oncology ... touchONCOLOGY, Andrew D Zelenetz , discusses the ... is placing an increasing burden on healthcare systems ... With the patents on many biologics expiring, interest ...
(Date:6/23/2016)... , June 22, 2016  Amgen (NASDAQ: ... the QB3@953 life sciences incubator to accelerate ... The shared laboratory space at QB3@953 was created to ... key obstacle for many early stage organizations - access ... the sponsorship, Amgen launched two "Amgen Golden Ticket" awards, ...
Breaking Biology Technology:
(Date:6/22/2016)... 2016 On Monday, the Department of Homeland ... share solutions for the Biometric Exit Program. The Request ... Protection (CBP), explains that CBP intends to add biometrics ... the United States , in order to deter ... Logo - ...
(Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
(Date:6/9/2016)... 9, 2016 Paris Police ... video security solution to ensure the safety of people and ... during the major tournament Teleste, an international technology ... services, announced today that its video security solution will be ... back up public safety across the country. The system roll-out ...
Breaking Biology News(10 mins):